| 臺大學術典藏 |
2018-09-10T08:42:47Z |
Tumor necrosis factor-α and interleukin-10 contribute to immunoparalysis in patients with acute pancreatitis
|
Ho, Y.-P.;Chiu, C.-T.;Sheen, I.-S.;Tseng, S.-C.;Lai, P.C.;Ho, S.-Y.;Chen, W.-T.;Lin, T.-N.;Lin, C.-Y.; Ho, Y.-P.; Chiu, C.-T.; Sheen, I.-S.; Tseng, S.-C.; Lai, P.C.; Ho, S.-Y.; Chen, W.-T.; Lin, T.-N.; Lin, C.-Y.; TSUNG-NAN LIN |
| 臺大學術典藏 |
2018-09-10T04:04:51Z |
Tumor necrosis factor-α and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma
|
Wu, M.-S. and Huang, S.-P. and Chang, Y.-T. and Shun, C.-T. and Chang, M.-C. and Lin, M.-T. and Wang, H.-P. and Lin, J.-T.; MING-TSAN LIN; YU-TING CHANG; MING-SHIANG WU; CHIA-TUNG SHUN |
| 臺大學術典藏 |
2002 |
Tumor necrosis factor-α and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma
|
Lin J.-T.; Wang H.-P.; MING-TSAN LIN; Wu M.-S.;Huang S.-P.;Chang Y.-T.;Shun C.-T.;Chang M.-C.;Ming-Tsan Lin;Wang H.-P.;Lin J.-T.; Wu M.-S.; Huang S.-P.; Chang Y.-T.; Shun C.-T.; Chang M.-C. |
| 臺大學術典藏 |
2021-01-15T03:48:01Z |
Tumor necrosis factor-α and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma
|
Wu M.-S.; Huang S.-P.; Chang Y.-T.; Shun C.-T.; Chang M.-C.; Lin M.-T.; HSIU-PO WANG; Lin J.-T. |
| 臺大學術典藏 |
2021-02-04T07:16:27Z |
Tumor necrosis factor-α and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma
|
Wu M.-S.; Huang S.-P.; YU-TING CHANG; Shun C.-T.; Chang M.-C.; Lin M.-T.; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2021-03-05T06:07:38Z |
Tumor necrosis factor-α and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma
|
Wu M.-S.; Huang S.-P.; Chang Y.-T.; Shun C.-T.; MING-CHU CHANG; Lin M.-T.; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2021-03-18T02:03:29Z |
Tumor necrosis factor-α and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma
|
Wu M.-S.; Huang S.-P.; Chang Y.-T.; CHIA-TUNG SHUN; Chang M.-C.; Lin M.-T.; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:22:35Z |
Tumor necrosis factor-α and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma
|
MING-SHIANG WU; Huang S.-P.; Chang Y.-T.; Shun C.-T.; Chang M.-C.; Lin M.-T.; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T08:56:52Z |
Tumor necrosis factor-α and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma
|
MING-SHIANG WU; Huang S.-P.; Chang Y.-T.; Shun C.-T.; Chang M.-C.; Lin M.-T.; Wang H.-P.; Lin J.-T. |
| 亞洲大學 |
2007 |
Tumor Necrosis Factor-α and Interleukin-4 Gene Polymorphisms in Chinese patients with Gout
|
Man-Ling Chen;Chung-Ming Huang;Chang-Hai Tsai;Fuu-Jen Tsai |
| 中國醫藥大學 |
2007 |
Tumor Necrosis Factor-α and Interleukin-4 Gene Polymorphisms in Chinese patients with Gout
|
陳曼伶(Man-Ling Chen); 黃春明(Chung-Ming Huang)*; 蔡長海(Chang-Hai Tsai); 蔡輔仁(Fuu-Jen Tsai) |
| 中國醫藥大學 |
2005-11-26 |
Tumor Necrosis Factor-α Gene Promoter Polymorphism in Chinese Patients with Systemic Lupus Erythematosus
|
黃麗雪(Li-Hsueh Huang); 黃春明(Chung-Ming Huang); 蔡輔仁(Tsai,Fuu-Jen) |
| 亞洲大學 |
2015-10 |
Tumor Necrosis Factor-α Genotypes Are Associated with Hepatocellular Carcinoma Risk in Taiwanese Males, Smokers and Alcohol Drinkers
|
Bau, MEI-DUE YANG；MEI-DUE YANG；CHIN-MU HSU；CHIN-MU HSU；WEN-SHIN CHA；WEN-SHIN CHANG；TE-CHENG YUE；TE-CHENG YUEH；YI-LIANG LAI；YI-LIANG LAI；CHIN-LIANG C；CHIN-LIANG CHUANG；SHOU-CHENG W；SHOU-CHENG WANG；LONG-BIN JEN；LONG-BIN JENG；CHENG-NAN WU；CHENG-NAN WU；CHIA-WEN TSA；CHIA-WEN TSAI；JING-GUNG CH；JING-GUNG CHUNG；包大?；Da-Tian |
| 亞洲大學 |
2015-10 |
Tumor Necrosis Factor-α Genotypes Are Associated with Hepatocellular Carcinoma Risk in Taiwanese Males, Smokers and Alcohol Drinkers
|
YANG), MEI-DUE YANG(MEI-DUE;HSU), CHIN-MU HSU(CHIN-MU;CHANG), WEN-SHIN CHA(WEN-SHIN;YUEH), TE-CHENG YUE(TE-CHENG;LAI), YI-LIANG LAI(YI-LIANG;CHUANG), CHIN-LIANG C(CHIN-LIANG;WANG), SHOU-CHENG W(SHOU-CHENG;JENG), LONG-BIN JEN(LONG-BIN;WU), CHENG-NAN WU(CHENG-NAN;TSAI), CHIA-WEN TSA(CHIA-WEN;CHUNG), JING-GUNG CH(JING-GUNG;Bau)*, 包大?(Da-Tian |
| 國立彰化師範大學 |
2009-03 |
Tumor Necrosis Factor-α Increases Inflammation and Interleukin-6 mRNA Expression of Murine Myoblast Cells Via FAK/PI3K/AKT and NF-κB Pathways
|
Su, Chen-Ming; Tang, Chih-Hsin; Tseng, Wen-Pei |
| 中國醫藥大學 |
2009-03-21 |
Tumor Necrosis Factor-α Increases Interleukin-6 Expression of Myoblasts via the FAK, PI3K, AKT and NF-κB Pathways
|
(Chen-Ming Su); 湯智昕(Tang Chih-Hsin); (Wen-Pei Tseng1) |
| 國立臺灣大學 |
2000 |
Tumor Necrosis Factor-α Renders Human Peritoneal Mesothelial Cells Sensitive to Anti-Fas Antibody-Induced Apoptosis
|
陳進陽; 戚謹文; 楊五常; 楊安航; CHEN, JINN-YANG; CHI, CHIN-WEN; CHEN, HUI-LING; YANG, AN-HANG |
| 臺大學術典藏 |
2018-09-10T04:37:32Z |
Tumor necrosis factor-α stimulates fractalkine production by mesangial cells and regulates monocyte transmigration: Down-regulation by cAMP
|
Chen, Y.-M. and Lin, S.-L. and Chen, C.-W. and Chiang, W.-C. and Tsai, T.-J. and Hsieh, B.-S.; SHUEI-LIONG LIN; TUN-JUN TSAI; WEN-CHIH CHIANG; YUNG-MING CHEN |
| 臺大學術典藏 |
2020-12-24T07:44:04Z |
Tumor necrosis factor-α stimulates fractalkine production by mesangial cells and regulates monocyte transmigration: Down-regulation by cAMP
|
Chen Y.-M.; Lin S.-L.; Chen C.-W.; Chiang W.-C.; TUN-JUN TSAI; Hsieh B.-S. |
| 臺大學術典藏 |
2021-01-12T03:32:33Z |
Tumor necrosis factor-α stimulates fractalkine production by mesangial cells and regulates monocyte transmigration: Down-regulation by cAMP
|
Chen Y.-M.;Shuei-Liong Lin;Chen C.-W.;Chiang W.-C.;Tsai T.-J.;Hsieh B.-S.; Chen Y.-M.; SHUEI-LIONG LIN; Chen C.-W.; Chiang W.-C.; Tsai T.-J.; Hsieh B.-S. |
| 臺大學術典藏 |
2003 |
Tumor necrosis factor-α stimulates fractalkine production by mesangial cells and regulates monocyte transmigration: Down-regulation by cAMP
|
Hsieh B.-S.; Tsai T.-J.; WEN-CHIH CHIANG; Chen C.-W.; Lin S.-L.; Chen Y.-M.; Chen Y.-M.;Lin S.-L.;Chen C.-W.;Wen-Chih Chiang;Tsai T.-J.;Hsieh B.-S. |
| 臺大學術典藏 |
2021-03-18T02:03:08Z |
Tumor necrosis factor-α stimulates the expression of C-C chemokine ligand 2 gene in fibroblasts from the human nasal polyp through the pathways of mitogen-activated protein kinase
|
Lin S.-K.;Kok S.-H.;Chia-Tung Shun;Hong C.-Y.;Wang C.-C.;Hsu M.-C.;Liu C.-M.; Lin S.-K.; Kok S.-H.; CHIA-TUNG SHUN; Hong C.-Y.; Wang C.-C.; Hsu M.-C.; Liu C.-M. |
| 臺大學術典藏 |
2021-07-06T09:26:33Z |
Tumor necrosis factor-α stimulates the expression of C-C chemokine ligand 2 gene in fibroblasts from the human nasal polyp through the pathways of mitogen-activated protein kinase
|
SZE-KWAN LIN; Kok S.-H.; Shun C.-T.; Hong C.-Y.; Wang C.-C.; Hsu M.-C.; Liu C.-M. |
| 臺大學術典藏 |
2021-07-06T04:08:57Z |
Tumor necrosis factor-α stimulates the expression of C-C chemokine ligand 2 gene in fibroblasts from the human nasal polyp through the pathways of mitogen-activated protein kinase
|
Lin S.-K.; SANG-HENG KOK; Shun C.-T.; Hong C.-Y.; Wang C.-C.; Hsu M.-C.; Liu C.-M. |
| 臺大學術典藏 |
2021-05-07T05:13:49Z |
Tumor necrosis factor-α, platelet-activating factor, and hydrogen peroxide activate protein kinase C subtypes α and ε in human saphenous vein endothelial cells
|
CHING-CHOW CHEN; Liau C.-S.; Lee Y.-T. |
| 臺大學術典藏 |
2018-09-10T07:40:52Z |
Tumor necrosis factor-α-238 and -308 polymorphisms do not associate with traits related to obesity and insulin resistance
|
CHUNG-JEN YEN; Walston, J. and Seibert, M. and Yen, C.-J. and Cheskin, L.J. and Andersen, R.E. |
| 臺大學術典藏 |
2020-10-14T06:31:09Z |
Tumor necrosis factor-α-238 and -308 polymorphisms do not associate with traits related to obesity and insulin resistance
|
Andersen R.E.; CHUNG-JEN YEN; Cheskin L.J.; Seibert M.; Walston J. |
| 亞洲大學 |
2004 |
Tumor necrosis factor-α-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas
|
Hsieh Yao-Yuan;Chi-Chen Chang;Fuu-Jen Tsai;Cheng-Chieh Lin;Lian-Shung Yeh;Chang-Hai Tsai |
| 中國醫藥大學 |
2004 |
Tumor necrosis factor-α-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas
|
謝耀元; 張其真(Chi-Chen Chang); 蔡輔仁(Fuu-Jen Tsai)*; 林正介(Cheng-Chieh Lin); 葉聯舜(Lian-Shung Yeh); 蔡長海(Chang-Hai Tsai) |
| 臺大學術典藏 |
2020-03-05T03:20:29Z |
Tumor necrosis factor-α-elicited stimulation of γ-secretase is mediated by c-Jun N-terminal kinase-dependent phosphorylation of presenilin and nicastrin
|
WEN-MING HSU; Tung Y.-T.; Wang B.-J.; Tsai W.-W.; Yen C.-T.; Liao Y.-F.; Kuo L.-H.; Hu M.-K. |
| 臺大學術典藏 |
2018-09-10T07:10:03Z |
Tumor necrosis factor-α-elicited stimulation of γ-secretase is mediated by c-Jun N-terminal kinase-dependent phosphorylation of presenilin and nicastrin
|
Kuo, L.-H.;Hu, M.-K.;Hsu, W.-M.;Tung, Y.-T.;Wang, B.-J.;Tsai, W.-W.;Yen, C.-T.;Liao, Y.-F.; Kuo, L.-H.; Hu, M.-K.; Hsu, W.-M.; Tung, Y.-T.; Wang, B.-J.; Tsai, W.-W.; Yen, C.-T.; Liao, Y.-F.; WEN-MING HSU; CHEN-TUNG YEN |
| 臺大學術典藏 |
2021-05-07T05:13:45Z |
Tumor necrosis factor-αinduced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and lκb kinase 1/2 in human alveolar epithelial cells
|
CHING-CHOW CHEN; Sun Y.-T.; Chen J.-J.; Chang Y.-J. |
| 臺大學術典藏 |
2008 |
Tumor Necrosis Factor-α–elicited Stimulation of γ-Secretase Is Mediated by c-Jun N-terminal Kinase-dependent Phosphorylation of Presenilin and Nicastrin
|
Kuo, Lan-Hsin; Hu, Ming-Kuan; Hsu, Wen-Ming; Tung, Ying-Tsen; Wang, Bo-Jeng; Tsai, Wang-Wei; Yen, Chen-Tung; Liao, Yung-Feng; Kuo, Lan-Hsin; Hu, Ming-Kuan; Hsu, Wen-Ming; Tung, Ying-Tsen; Wang, Bo-Jeng; Tsai, Wang-Wei; Yen, Chen-Tung; Liao, Yung-Feng |
| 國立臺灣大學 |
2008 |
Tumor Necrosis Factor-α–elicited Stimulation of γ-Secretase Is Mediated by c-Jun N-terminal Kinase-dependent Phosphorylation of Presenilin and Nicastrin
|
Kuo, Lan-Hsin; Hu, Ming-Kuan; Hsu, Wen-Ming; Tung, Ying-Tsen; Wang, Bo-Jeng; Tsai, Wang-Wei; Yen, Chen-Tung; Liao, Yung-Feng |
| 國立臺灣大學 |
2001-12 |
Tumor necrosis factor--induced apoptosis in cord blood T lymphocytes: involvement of both tumor necrosis factor receptor types 1 and 2
|
Yang, Ya-Chien; Hsu, Tsuey-Ying; Chen, Jen-Yang; Yang, Czau-Siung; Lin, Rong-Hwa |
| 臺大學術典藏 |
2020-11-02T02:05:30Z |
Tumor necrosis factor-�\ and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma
|
Wang H.-P.; Lin J.-T.; Lin M.-T.; Chang M.-C.; Shun C.-T.; Chang Y.-T.; Huang S.-P.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:47:56Z |
Tumor necrosis factor: The key to hepatitis B viral clearance
|
Chyuan I.-T.; PING-NING HSU |
| 中國醫藥大學 |
2014-08-28 |
Tumor necrosis factors, molds and Asthma in Children: A Haplotype-Based Analysis.
|
黃鈺斯(Yu-Sih Huang);李郁芬(Yu-Fen Li);戴婷豫(Ting-Yu Tai);林育廷(Yu-Ting Lin);黃彬芳(Bing-Fang Hwang);黃彬芳(Bing-Fang Hwang) |
| 國立臺灣大學 |
2001 |
Tumor necrosis factor-induced activation of downstream NF-kB site of the promoter mediates epithelial ICAM-1 expression and monocyte adhesion: Involvement of PKC, tyrosine kinase and IKK2, but not MAPKs
|
Chen, Ching-Chow; Chou, Chian-Ying; Sun, Yi-Tao; Huang, Wei-Chien |
| 國立成功大學 |
2021-07 |
Tumor Necrosis with Adjunction of Preoperative Monocyte-to-Lymphocyte Ratio as a New Risk Stratification Marker Can Independently Predict Poor Outcomes in Upper Tract Urothelial Carcinoma
|
Lin;Kun-Che;Jan;Hau-Chern;Hu;Che-Yuan;Ou;Yin-Chien;Kao;Yao-Lin;Yang;Wen-Horng;Ou;Chien-Hui |
| 國立臺灣大學 |
2007-11 |
Tumor necrotizing factor-a and GST-T1 genotype predict skin allergy to chromate in cement workers in Taiwan
|
Wang, BJ; Shiao, JSC; Chen, CJ; Lee, YC; Guo, YL |
| 臺大學術典藏 |
2020-05-26T09:26:34Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Yu C.-J.;Chih-Hsin Yang;Shih J.-Y;Lin C.-C;Lee J.-H;Chang Y.-L;Su K.-Y;Hsu W.-H;Hsu C.-L;Tsai T.-H;Chen K.-Y;Liao W.-Y;Ho C.-C;Liao B.-C;Yang C.-Y;Lin S.-Y; Lin S.-Y; Yang C.-Y; Liao B.-C; Ho C.-C; Liao W.-Y; Chen K.-Y; Tsai T.-H; Hsu C.-L; Hsu W.-H; Su K.-Y; Chang Y.-L; Lee J.-H; Lin C.-C; Shih J.-Y; CHIH-HSIN YANG; Yu C.-J. |
| 臺大學術典藏 |
2020-06-30T08:09:57Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Kang-Yi Su;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; KANG-YI SU; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:21Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin C.-C.; Lee J.-H.; Chang Y.-L.; Su K.-Y.; Hsu W.-H.; Hsu C.-L.; Tsai T.-H.; Chen K.-Y.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; CHAO-CHI HO; Liao W.-Y.; Yu C.-J.; Yang J.C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-13T06:33:33Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Yang J.C.; Yu C.-J.; JIN-YUAN SHIH; Lin C.-C.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Chen K.-Y.; Liao W.-Y.; Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C. |
| 臺大學術典藏 |
2018 |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Chia-Lin Hsu;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; CHIA-LIN HSU; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2021-04-29T02:38:33Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Anonymous |
| 臺大學術典藏 |
2021-08-31T03:33:45Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
SHU-YUNG LIN; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:35Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2021-04-29T05:08:54Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; KUAN-YU CHEN; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
